Stocks rose to begin a busy week that will see a flurry of corporate earnings reports, with investors also awaiting further ...

Significant proteinuria reduction maintained at one year, regardless of immunosuppressant use or baseline proteinuria levels Complete proteinuria ...

The ICAIs Preface defines Internal Audit as providing assurance on internal controls and risk management processes to enhance ...

Allied will release its third quarter 2025 financial results after the market closes on Wednesday, November 5, 2025. The Company will then host a conference call and webcast to review the results on ...

And that computing power has a big environmental footprint. A typical AI data center uses as much electricity as 100,000 ...

Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

Q3 2025 Earnings Call October 20, 2025 8:30 AM EDTCompany ParticipantsLourenco Goncalves - Chairman, President ...

Experts warn Trump’s preferential funding deal, which is now being offered to all U.S. universities and colleges, threatens ...

Safety primary endpoint achieved Median treatment duration of 4 months with a range of 2 to 12 months and three patients remain on trial RECIST data with apparent ...

The statements regarding Herpafend have not been evaluated by the Food and Drug Administration (FDA). This product is not ...

Akari Therapeutics, Plc (Nasdaq: AKTX) (the “Company”), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that it has entered into a ...

Following volatility in early 2025, family offices are transforming caution into opportunity to position themselves for ...